Straits Times Index
3,301.39 +8.70 (+0.26%) Nikkei
38,268.30 -5.75 (-0.02%) Hang Seng
18,174.72 +411.69 (+2.32%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,429.23 -2,657.85 (-4.42%) CMC Crypto 200
1,256.52 -82.55 (-6.16%)
NVO Jan 2025 70.000 call
| Previous close | 60.77 |
| Open | 60.76 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 70.00 |
| Expiry date | 2025-01-17 |
| Day's range | 60.76 - 60.77 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Yahoo Finance Video
Apple, Novo Nordisk earnings, jobless claims: What to watch
A number of companies release their quarterly earning reports on Thursday, including Apple (AAPL), Novo Nordisk (NVO), Shell (SHEL), ConocoPhillips (COP), Cigna (CI), Coinbase (COIN), Moderna (MRNA), DraftKings (DKNG), Kellanova (K), United States Steel (X), and more. On the economic front, jobless claims for the week ending on April 27 will be released. Economists expect claims to rise to 212,000 from 207,000 the prior week. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Nicholas Jacobino
- Reuters
FOCUS-British pharmacies vie for weight-loss patients with drug price cuts
Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain just months after the weight-loss drugs were launched there, as initial supply shortages ease. But growing competition between retailers has raised fears that some patients who buy the drugs themselves, rather than relying on the National Health Service (NHS), will miss out on long-term aftercare if they keep switching providers.
GlobeNewswireNovo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 1 May 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme init
